MorganRosel Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
MorganRosel Wealth Management's MRNA Position: Q3 2025 in Review
MorganRosel Wealth Management sold out of Moderna (MRNA) in Q3 2025, closing a stake of 67 shares — an estimated $1.85K sold.
MorganRosel Wealth Management first reported a position in MRNA in Q1 2025 and held it in 2 quarters. The position peaked at $1.9K in Q1 2025. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.
- MorganRosel Wealth Management reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
- MorganRosel Wealth Management sold 67 Moderna shares in Q3 2025, an estimated $1.85K.
- MorganRosel Wealth Management first reported a position in Moderna in Q1 2025 and held it in 2 quarters.
- MorganRosel Wealth Management's Moderna position peaked at $1.9K in Q1 2025.
- 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.
Based on MorganRosel Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.